Chronic Myeloid Leukemia Patients Were Not Different In Molecular Relapse After Stopping Imatinib In Mr4 Whether Residual Disease Was Detected Or Not - When Adjusting For Number Of Control Transcripts
AuthID
P-01B-03C
P-01B-03C